You are now viewing 1 - 4 of 4 results
May 1, 2012 | Journal Article
Value-based insurance design bases cost sharing on a medication's clinical value, not its price. This study shows the effectiveness of value-based insurance design.
June 1, 2011 | Journal Article
A decrease in prescription length and an increase in brand-name co-payment decreased medication adherence in North Carolina.
November 1, 2010 | Journal Article
A large value-based insurance design program offered by Blue Cross Blue Shield of North Carolina eliminated generic medication copayments and reduced copayments for brand-name medications.
January 1, 2001 | Program Result
During the 1980s, expenditures on pharmaceuticals nationwide increased by 152 percent. HMOs implemented a number of cost-control mechanisms to slow the rate of growth of pharmaceutical expenditures, and were successful in doing so compared to fee-for-service health plans.